KCR Launches Innovative CTMS Platform in Cooperation with Quadratek

KCR Launches Innovative CTMS Platform in Cooperation with Quadratek

Contract Research Organization realizes the e-company strategy to streamline clinical study processes and assure data transparency

January 27, 2015 05:00 AM Eastern Standard Time

WARSAW, Poland--(BUSINESS WIRE)--KCR, a Contract Research Organization (CRO) operating across 19 European countries and in the U.S., is developing an innovative clinical trial data platform based on the Clincase electronic data capture (EDC) and clinical data management (CDM) software delivered by Quadratek Data Service.

The platform will be an intuitive and low maintenance tool for site and project management in the same environment that is already used for EDC, Interactive Web Response System (IWRS), Drug Supply, and Investigational Medicinal Product (IMP) management. By operationalizing the Clincase technology KCR will provide its clients with an innovative Clinical Trial Management System (CTMS) platform assuring full electronic data access.

"Innovate or die – needless to say, the CRO industry cannot afford to ignore the words these days. We have to respond to market tendencies, but more importantly, we have to set up new trends by using an innovative approach to efficiently respond to old and new clinical trial execution challenges," said Mike Jagielski, President & CEO of KCR. "Our cooperation project with Quadratek provides KCR with an advanced technology solution to respond to market needs such as Risk Based Monitoring (RBM) or to industry efforts to increase the level of clinical trial transparency."

KCR aim when starting the Clincase platform project was to set up a technology solution that combines high degree of adjustability to the client needs with low maintenance requirements. "Thanks to these features the platform is cost-effective and therefore attractive for both biotech and mid-sized pharma companies. We focus on providing innovative world-class solutions to all our clients and we are committed to do so," added Mr. Jagielski.

The CTMS platform will provide transparency of processes and bring expertise and know-how into one of the most work-intensive and data-heavy areas of a clinical trial. The CTMS will be integrated into the existing Clincase architecture. The end product will be an innovative system offering increased capacities for overall trial management while maintaining high-level functionalities for data management (DM) and IMP supervision. The solution will also deliver in-built randomization support.

Martin Nöör, KCR CTMS Implementation Lead, added: "Clinical studies are becoming more and more complex in the operating environment. The innovative CTMS platform will allow increased management and control over multi-centered, international clinical trials thanks to a repository hub, providing detailed information for risk assessment and mitigation. KCR will benefit from centralized and real-time access to metrics and Key Performance Indicators (KPIs) by obtaining excellent oversight of the project activities."

KCR will provide its clients with access to the CTMS in February 2015. If you would like to learn more about KCR's CTMS platform and/or about KCR services, please contact Joanna Lewandowska, PR & Marketing, at [email protected]

About KCR

KCR is a Contract Research Organization (CRO) operating across 19 countries in Europe as well as the U.S. The company is a strategic solutions provider for pharmaceutical and biotechnology firms who are looking for a reliable alternative to top tier CROs. Over 300 professionals offer full service capabilities in three main product lines: Trial Execution, Functional Service Provision (FSP) and Late Phase, across a wide range of therapeutic areas. Focusing on knowledge, quality and innovation, KCR with its services supports 12 of the Top 20 Global Pharma companies, as well as biotech firms from Europe, Israel and the U.S. on long-standing contracts. For more please visit: www.kcrcro.com.

KCR: We see human behind every number.

Contacts